Best Practices for Conducting Clinical Trials With Indigenous Children in the United States

Jennifer L Shaw1, Erin Semmens1, May Okihiro1

  • 1Jennifer L. Shaw and Denise A. Dillard are with the Southcentral Foundation Research Department, Anchorage, AK. Rosalyn Singleton is with the Alaska Native Tribal Health Consortium, Anchorage. May Okihiro and David Easa are with the University of Hawaii at Manoa, Honolulu. Erin Semmens, Paul G. Smith, and Niki Graham are with the University of Montana, Missoula. Johnnye L. Lewis is with the University of New Mexico Health Sciences Center, Albuquerque. Matthew Hirschfeld is with the Alaska Native Medical Center, Anchorage. Timothy M. VanWagoner, Paul M. Darden, Edgardo G. Szyld, and Lancer Stephens are with the University of Oklahoma Health Sciences Center, Oklahoma City. Judith L. Ross is with the Alfred I. duPont Hospital for Children, Wilmington, DE. Sara E. Watson is with the University of Louisville, Louisville, KY. Lee A. Pyles is with the West Virginia University, Morgantown. John C. Carlson is with Tulane University, New Orleans, LA. Russell J. McCulloh is with the University of Nebraska Medical Center, Omaha. Jessica N. Snowden is with the University of Arkansas for Medical Sciences, Little Rock. Sarah H. Adeky is with the Ramah Navajo Community, Pinehill, NM.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
24.9K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
26
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
43